Tomgene Bio Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 13-12-2024
- Paid Up Capital ₹ 1.25 Cr
as on 13-12-2024
- Company Age 2 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.75 Cr
as on 13-12-2024
About Tomgene Bio
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.25 Cr.
The company currently has active open charges totaling ₹3.75 Cr.
Padmanabhan Chedambath, Shalini Kurian, Mini Padmanabhan, and One other member serve as directors at the Company.
- CIN/LLPIN
U33100KL2022PTC079001
- Company No.
079001
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Nov 2022
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thrissur, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Tomgene Bio?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Padmanabhan Chedambath  | Director | 26-Dec-2022 | Current |
| Shalini Kurian | Director | 23-Nov-2022 | Current |
| Mini Padmanabhan | Director | 23-Nov-2022 | Current |
| Kuruppassery Tomy | Director | 23-Nov-2022 | Current |
Financial Performance of Tomgene Bio.
Enhance accessibility to Tomgene Bio's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Tomgene Bio?
Unlock access to Tomgene Bio's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Multiline Energy Equipments Private LimitedActive 14 years 3 monthsPadmanabhan Chedambath and Kuruppassery Tomy are mutual person
Multiline Industries Private LimitedActive 11 years 10 monthsPadmanabhan Chedambath and Kuruppassery Tomy are mutual person
Multiline Polymers Private LimitedActive 10 years 11 monthsPadmanabhan Chedambath and Kuruppassery Tomy are mutual person
- Fine Trading And Agro Products Private LimitedActive 13 years 11 months
Kuruppassery Tomy is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Mar 2023 | ₹3.00 M | Open |
Sidbi Creation Date: 22 Feb 2023 | ₹3.45 Cr | Open |
How Many Employees Work at Tomgene Bio?
Tomgene Bio has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tomgene Bio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tomgene Bio's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
